SCHEMBL6920280

SCHEMBL6920280

Cc1nc2ccc(OCCCC(=O)O)cc2n1CCc1ncc(C(F)(F)F)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 4/20 0.42
PDE3A Q14432 4/20 0.42
P2RY12 Q9H244 2/20 0.42
MCL1 Q07820 1/20 0.41
PDE2A O00408 2/20 0.41
FFAR4 Q5NUL3 1/20 0.41
ALOX5AP P20292 4/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
DRD2 P14416 1/20 0.38
FFAR1 O14842 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6490952 0.91 ALOX5AP (0.43) PDE3BPDE3AP2RY12MCL1PDE2A
SCHEMBL6922928 0.86 MCL1 (0.41) MCL1FFAR4MEN1KMT2AMAPT
SCHEMBL6497506 0.82 PDE3B (0.43) PDE3BPDE3AP2RY12ALOX5APMEN1
SCHEMBL7196037 0.82 PPARG (0.41) ALOX5APMEN1KMT2A
SCHEMBL6920283 0.80 FFAR4 (0.41) PDE3BPDE3AP2RY12MCL1PDE2A
SCHEMBL7196031 0.80 MRGPRX4 (0.42) MCL1ALOX5APMEN1KMT2AMAPT
SCHEMBL6497809 0.78 MCL1 (0.41) MCL1FFAR4MEN1KMT2AMAPT
SCHEMBL6502820 0.76 ALOX5AP (0.42) ALOX5APMEN1KMT2ANPSR1ALDH1A1
SCHEMBL6488591 0.74 ALOX5AP (0.44) MCL1ALOX5AP
SCHEMBL6501536 0.73 PPARG (0.52) PDE3BPDE3AP2RY12MCL1PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004108686-A2 BENZIMIDAZOLE COMPOUNDS HAVING HYPOGLYCEMIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-12-16 WO disclosed